XML 130 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income (loss) $ 334,325 $ (18,326) $ 180,208
Adjustments to reconcile net income (loss) to cash flows from operating activities:      
Provision for (recovery of) loan losses 6,482 16,937 (5,828)
Impairment of assets 13,419 147,108 32,379
Depreciation and amortization 58,259 58,699 49,934
Non-cash interest income from sales-type leases (3,781)    
Stock-based compensation expense 30,436 17,563 18,812
Amortization of discounts/premiums and deferred financing costs on debt obligations, net 13,847 15,422 13,857
Amortization of discounts/premiums and deferred interest on loans, net (42,342) (41,168) (55,985)
Deferred interest on loans received 10,397 40,463 52,795
Gain from consolidation of equity method investment 0 (67,877) 0
Gain from discontinued operations 0 0 (123,418)
Selling profit from sales-type leases (180,416)    
Losses (earnings) from equity method investments (41,849) 5,007 (13,015)
Distributions from operations of other investments 30,058 18,133 42,059
Deferred operating lease income (16,185) (14,989) (6,830)
Income from sales of real estate (236,623) (126,004) (92,557)
Land development revenue in excess of cost of sales (9,932) (59,529) (15,963)
Loss on early extinguishment of debt, net 27,724 10,367 14,724
Other operating activities, net 13,642 3,377 16,878
Changes in assets and liabilities:      
Changes in accrued interest and operating lease income receivable, net 417 949 1,424
Changes in deferred expenses and other assets, net (5,848) (1,925) (15,230)
Changes in accounts payable, accrued expenses and other liabilities, net (47,655) (28,335) 7,299
Cash flows provided by (used in) operating activities (45,625) (24,128) 101,543
Cash flows from investing activities:      
Originations and fundings of loans receivable, net (255,804) (482,143) (522,269)
Capital expenditures on real estate assets (39,946) (60,495) (37,067)
Capital expenditures on land and development assets (117,514) (128,543) (121,400)
Acquisitions of real estate, net investments in leases and land assets (240,487) (19,454) (6,600)
Repayments of and principal collections on loans receivable and other lending investments, net 419,800 832,982 615,620
Net proceeds from sales of loans receivable 5,898 0 0
Net proceeds from sales of real estate 329,971 411,786 314,013
Net proceeds from sales of land and development assets 114,885 223,416 194,090
Cash, cash equivalents and restricted cash acquired upon consolidation of equity method investment 0 13,608 0
Distributions from other investments 62,911 40,804 49,672
Contributions to and acquisition of interest in other investments (656,720) (94,578) (224,219)
Other investing activities, net (21,090) 41,476 1,231
Cash flows provided by investing activities (398,096) 778,859 263,071
Cash flows from financing activities:      
Borrowings from debt obligations 1,486,980 704,360 2,288,654
Repayments and repurchases of debt obligations (1,482,558) (944,800) (1,921,699)
Purchase of marketable securities in connection with the defeasance of mortgage notes payable 0 (110,939) 0
Preferred dividends paid (32,495) (32,496) (48,444)
Common dividends paid (25,059) (12,227) 0
Repurchase of stock (68,289) (8,304) (45,928)
Redemption of Series E and F preferred stock 0 0 (240,000)
Payments for deferred financing costs (19,928) (5,471) (32,419)
Payments for withholding taxes upon vesting of stock-based compensation (4,475) (4,807) (724)
Contributions from noncontrolling interests 2,812 13,927 12
Distributions to and redemption of noncontrolling interests (14,998) (60,743) (26,213)
Payments for debt prepayment or extinguishment costs (20,606) (4,132) (14,108)
Other financing activities, net (13) 7,693 (611)
Cash flows used in financing activities (178,629) (457,939) (41,480)
Effect of exchange rate changes on cash 12 19 (28)
Changes in cash, cash equivalents and restricted cash (622,338) 296,811 323,106
Cash, cash equivalents and restricted cash at beginning of period 974,544 677,733 354,627
Cash, cash equivalents and restricted cash at end of period 352,206 974,544 677,733
Supplemental disclosure of cash flow information:      
Cash paid during the period for interest, net of amount capitalized 181,520 171,590 179,208
Supplemental disclosure of non-cash investing and financing activity:      
Fundings and repayments of loan receivables and loan participations, net 13,014 (80,095) (57,514)
Sales-type lease origination 411,523 0 0
Acquisitions of real estate and land and development assets through deed-in-lieu 0 4,600 0
Contributions of real estate and land and development assets to equity method investments, net 4,073 0 0
Accounts payable for capital expenditures on land and development assets 0 16,052 3,775
Marketable securities transferred in connection with the defeasance of mortgage notes payable 0 110,939 0
Accounts payable for capital expenditures on real estate assets 0 0 2,709
Acquisition of land and development asset through joint venture consolidation 27,000 0 0
Conversion of Series J convertible preferred stock 193,510 0 0
Defeasance of mortgage notes payable 0 (105,785) 0
Receivable from sales of real estate and land parcels 0 0 4,853
Accrued finance costs 2,362 0 0
Accrued stock repurchases 6,358 0 0
Assumption of mortgage by third party 228,000 0 0
Financing provided on sales of land and development assets, net 0 142,639 0
Increase in net lease assets upon consolidation of equity method investment 0 844,550 0
Increase in debt obligations upon consolidation of equity method investment 0 464,706 0
Increase in noncontrolling interests upon consolidation of equity method investment $ 0 $ 200,093 $ 0